Advisory Services Network’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding SAGE
BG
Advisory Services Network's SAGE Position: Q1 2023 in Review
Advisory Services Network sold out of Sage Therapeutics (SAGE) in Q1 2023, closing a stake of 3,010 shares — an estimated $115K sold.
Advisory Services Network first reported a position in SAGE in Q3 2020 and held it in 3 quarters. The position peaked at $115K in Q4 2022. 213 funds tracked by Wall St. Rank hold SAGE as of Q1 2023.
- Advisory Services Network reported no remaining Sage Therapeutics position as of Q1 2023 after selling out during the quarter.
- Advisory Services Network sold 3,010 Sage Therapeutics shares in Q1 2023, an estimated $115K.
- Advisory Services Network first reported a position in Sage Therapeutics in Q3 2020 and held it in 3 quarters.
- Advisory Services Network's Sage Therapeutics position peaked at $115K in Q4 2022.
- 213 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2023.
Based on Advisory Services Network's 13F filing for Q1 2023, filed 17 May 2023.